data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
VolitionRX
(AMEX:VNRX)
$2.01
00
At close: Jul 1
$2.01
00
PreMarket: 4:31PM EDT
Day High/Low- - -
52 Week High/Low1.95 - 4.14
Open / Close- / -
Float / Outstanding45.4M / 63.6M
Vol / Avg.- / 61K
Mkt Cap127.7M
P/E-
50d Avg. Price2.4
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float45.4M

VolitionRX (AMEX:VNRX), Quotes and News Summary

VolitionRX (AMEX: VNRX)

Day High/Low- - -
52 Week High/Low1.95 - 4.14
Open / Close- / -
Float / Outstanding45.4M / 63.6M
Vol / Avg.- / 61K
Mkt Cap127.7M
P/E-
50d Avg. Price2.4
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float45.4M
Benzinga - May 31, 2022, 8:10AM
Benzinga - May 20, 2022, 4:06PM
Benzinga - May 11, 2022, 4:20PM
Benzinga - Apr 16, 2022, 6:10AM
Benzinga - Mar 30, 2022, 4:11PM
Benzinga - Mar 29, 2022, 8:02AM
Benzinga - Dec 16, 2021, 8:02AM
Benzinga - Nov 22, 2021, 10:03AM
Benzinga - Nov 16, 2021, 9:01AM
Benzinga - Nov 10, 2021, 5:22PM
Benzinga - Nov 4, 2021, 9:13AM
Benzinga - Aug 18, 2021, 3:37PM
Benzinga - Aug 18, 2021, 3:37PM
Benzinga - Aug 11, 2021, 4:32PM
Benzinga - Jul 22, 2021, 8:05AM
VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS0.020-0.140 -0.1600
REV10.030M114.211K-9.916M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

VolitionRX Questions & Answers

Q
How do I buy VolitionRX (VNRX) stock?
A

You can purchase shares of VolitionRX (AMEX: VNRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are VolitionRX's (VNRX) competitors?
A

There are no as such competitors for VolitionRX.

Q
What is the target price for VolitionRX (VNRX) stock?
A

The latest price target for VolitionRX (AMEX: VNRX) was reported by Aegis Capital on Tuesday, November 16, 2021. The analyst firm set a price target for 9.00 expecting VNRX to rise to within 12 months (a possible 347.76% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for VolitionRX (VNRX)?
A

The stock price for VolitionRX (AMEX: VNRX) is $2.01 last updated July 1, 2022, 7:59 PM UTC.

Q
Does VolitionRX (VNRX) pay a dividend?
A

There are no upcoming dividends for VolitionRX.

Q
When is VolitionRX (AMEX:VNRX) reporting earnings?
A

VolitionRX’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is VolitionRX (VNRX) going to split?
A

There is no upcoming split for VolitionRX.

Q
What sector and industry does VolitionRX (VNRX) operate in?
A

VolitionRX is in the Healthcare sector and Diagnostics & Research industry. They are listed on the AMEX.